Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
MAJOR ARTICLE Association between Interleukin-8 Gene Alleles and Human Susceptibility to Tuberculosis Disease Xin Ma,1 Robert A. Reich,1 John A. Wright,1 Heather R. Tooker,1 Larry D. Teeter,1 James M. Musser,3 and Edward A. Graviss1,2 Departments of 1Pathology and 2Medicine, Baylor College of Medicine, Houston, Texas; 3Laboratory of Human Bacterial Pathogenesis, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana Interleukin (IL)–8 is involved in the pathogenesis of human tuberculosis (TB). However, the contribution of polymorphisms of the IL-8 gene and its receptor genes CXCR-1 and CXCR-2 to human TB susceptibility remains untested. In a case-control study, white subjects with TB disease were more likely to be homozygous for the IL-8 ⫺251A allele, compared with control subjects (odds ratio [OR], 3.41; 95% confidence interval [CI], 1.52–7.64). African Americans with TB also showed an increased odds of being homozygous for this allele (OR, 3.46; 95% CI, 1.48–8.08). To exclude population artifacts in the case-control study, a separate analysis that used a transmission-disequilibrium test with 76 informative families confirmed that the IL-8 ⫺251A allele was preferentially transmitted to TB-infected children (P p .02 ). CXCR-1 and CXCR-2 did not demonstrate significant associations with TB susceptibility. These data suggest that IL-8 is important in the genetic control of human TB susceptibility. Interleukin (IL)–8 is an important chemokine in the human inflammatory process and functions as a potent chemoattractant for the recruitment of leukocytes to inflammatory sites [1–3]. In particular, the role of IL8 in human tuberculosis (TB) disease has become a major focus for TB researchers worldwide. Initially, clinical and pathological observations have shown remarkably elevated levels of IL-8 in tuberculous pleural exudate [4], bronchoalveolar lavage fluid [5], and cerebrospinal fluid [6]. IL-8 also is expressed predominantly in tuberculous granulomas heavily infiltrated by neutrophils [7]. In addition, several studies have demonstrated that IL-8 concentrations in plasma are higher in patients who die from TB than in survivors [2, 8]. In response to anti-TB treatments, IL-8 in sputum closely parallels and even precedes mycobacterial clearance in the sputum [9]. Further studies reveal that IL- Received 8 January 2003; accepted 4 March 2003; electronically published 10 July 2003. Financial support: National Institute of Allergy and Infectious Diseases, National Institutes of Health (contracts N01-AO-02738 and AI-41168). Reprints or correspondence: Dr. Edward A. Graviss, Dept. of Pathology (209E), Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030 (egraviss@ bcm.tmc.edu). The Journal of Infectious Diseases 2003; 188:349–55 2003 by the Infectious Diseases Society of America. All rights reserved. 0022-1899/2003/18803-0002$15.00 8 is produced and released by leukocytes [10–13] and structure cells [13–16] in response to Mycobacterium tuberculosis or its components. Pulmonary epithelial cells, covering a 70-m2 surface area, are a major source of IL-8 in the lungs [17]. Recent studies confirm that expression of the IL-8 gene is up-regulated in human macrophages infected with M. tuberculosis through the protein tyrosine kinases and NF-kB [18] and comprises part of the macrophage activation program [19]. In vivo, anti–IL-8 antibody inhibits granuloma formation in rabbits, which suggests that IL-8 may be central in host defense to M. tuberculosis [20]. Two types of IL8 receptors, CXCR-1 and CXCR-2, have been identified and found to be present in equal ratios on all polymorphonuclear leukocytes (PMNLs), monocytes (CXCR 2 dominant), and 5%–25% of total lymphocytes (CXCR-2 dominant) [21]. Functional studies have shown that both CXCR-1 and CXCR-2 mediate chemotaxis, the release of granule enzymes, and changes in cytosolic free calcium ions. However, only CXCR-1 triggers activation of phospholipase D and the respiratory burst [22]. Strikingly, surface expression of CXCR-1 and CXCR-2 is down-regulated on PMNLs from human immunodeficiency virus (HIV) type 1–infected individuals and patients coinfected with M. tuberculosis and HIV-1 [23]. Down-regulation of both IL-8 and Human Tuberculosis • JID 2003:188 (1 August) • 349 receptors in PMNLs from infected individuals is directly related to impaired IL-8–induced degranulation [24]. These findings suggest that limited IL-8–dependent PMNL degranulation in HIV-1–infected individuals may increase susceptibility to secondary microbial infections by organisms such as M. tuberculosis. Recently, a population-based case-control study described an association between systemic sclerosis and 2 polymorphisms (CXCR-2 +785TrC, CXCR-2 +1208CrT) in the CXCR-2 gene [25]. Family-based association studies suggested that a polymorphic allele (IL-8 ⫺251A) of IL-8, which shows a trend toward an association with increased IL-8 production by lipopolysaccharide-stimulated whole blood, determined susceptibility and severity of bronchiolitis after respiratory syncytial virus infections [26, 27]. At present, associations between these polymorphisms in IL-8, CXCR-1, and CXCR-2 genes and human TB susceptibility remain untested. Within an ongoing population-based TB surveillance study, Houston Tuberculosis Initiative (HTI), we conducted a population-based case-control study with adults with TB and control subjects without TB to test the possible association between these polymorphisms in IL-8, CXCR-1, and CXCR-2 genes and human TB susceptibility. Subsequently, a family-based transmission-disequilibrium test (TDT) with children with TB, and their parents and siblings was performed to exclude bias and false association due to population structure in the adult case-control study. PATIENTS AND METHODS Genetic polymorphisms in the IL-8, CXCR-1, and CXCR-2 genes and genotyping strategy. Nine sequence variants in the IL-8, 1 in CXCR-1, and 3 in CXCR-2 gene regions have been reported in the previous studies [25, 27]. The IL-8 polymorphisms are all located in the noncoding regions of the gene. The ethnic difference on the allele frequencies of these polymorphisms has been observed [27]. The single-nucleotide polymorphism (SNP) in CXCR-1 is located in exon 2, resulting in a conservative amino acid substitution from serine to threonine. One SNP in exon 11 of CXCR-2 results in a synonymous codon change, and the other 2 SNPs are located in noncoding regions [25]. Some of these variants are either rarely present in populations, or in strong linkage disequilibrium [25]. On the basis of implications from other studies [25–27] and our preliminary data (not shown), we selected and analyzed only 1 SNP from each of 3 genes (⫺251TrA in 5 promoter of IL-8, +2607GrC in exon 2 of CXCR-1, and +785CrT in exon 11 of CXCR-2). DNA was isolated from blood samples by use of the Nucleon DNA extraction and purification kit (Amersham International and Scotlab). Allele-specific PCR was used in genotyping of subjects, as described elsewhere [25–27]. Results of allele-specific PCRs were analyzed independently in a blinded fashion by 2 molecular biologists. 350 • JID 2003:188 (1 August) • Ma et al. Adult case-control study. One hundred six adult white patients with clinical TB disease (mean SD age, 51.2 11.2 years; 74.4% men) were collected from the HTI database, including 92 patients with pulmonary TB, 11 with extrapulmonary TB, and 3 with both pulmonary and extrapulmonary TB. All patients were identified by either M. tuberculosis culture positivity (n p 103) or clinical improvement in response to antimycobacterial treatment (n p 3 ). One hundred eighty adult African American patients with TB (age, 46.6 9.7 years; 63.9% men) received a diagnosis via culture positivity (n p 174) and clinical improvement to anti-TB treatment (n p 6), including 152 patients with pulmonary TB, 20 patients with extrapulmonary TB, and 8 patients with both. A total of 107 whites (age, 56.4 9.8 years; 55.6% men) and 167 African Americans (age, 41.9 10.9 years; 60.4% men) without a history of TB disease, autoimmune diseases, and other infectious diseases were recruited from local hospitals and clinics as control subjects for this study. All patients and control subjects were HIV seronegative. Race and ethnicity was determined for each individual by self-identification. White was defined as a non-Hispanic individual in this study. Frequencies of genotypes between the case patients and control subjects in each ethnic group were compared by x2 test for 2 ⫻ 2 contingency tables with SAS software (version 8.0; SAS Institute). P values were corrected for multiple comparisons by the formula Pcorr p 1 ⫺ (1 ⫺ P)n, where P is the uncorrected P value and n is the number of comparisons. Pcorr ! .05 was considered to be statistically significant. TDT within the families of children with TB. Findings in the adult case-control study were verified by conducting a family-based case-control study that used TDT [28]. One hundred thirty-one nuclear families, consisting of 159 children with TB (table 1) and 469 family members, were enrolled and blood samples drawn through the HTI. These cases were identified Table 1. Demographic and clinical features of children with tuberculosis (TB) from the Houston Tuberculosis Initiative. Characteristic Value Total no. children with TB 159 Age, mean years (range) 7.55 (0.17–18.00) Male sex 75 (47.2) Ethnicity Hispanic 90 (56.6) African American 47 (29.6) Other race 22 (13.8) Pulmonary TB 70 (44.0) Lymphatic TB 56 (35.2) TB at other sites 33 (20.8) NOTE. noted. Data are no. (%) of subjects, except where either by M. tuberculosis culture positivity (n p 76 ) or clinical improvement while receiving TB treatment (n p 83 ) after contact investigation. Twenty families had 11 child with TB. Twenty-one families did not included both parents but did include at least 1 unaffected sibling, who could be analyzed by the Sib-TDT (S-TDT) [29]. Because S-TDT is generally less powerful than conventional TDT, we used conventional TDT for those families that could be analyzed by either test. Finally, we combined TDT and S-TDT into an overall test, as described by Spielman et al. [29]. This study was approved by the Institutional Review Board for Baylor College of Medicine and Affiliated Hospitals. RESULTS Association between the IL-8 5251A allele and adult clinical TB disease. A total of 213 white and 347 African American subjects from adult case and control groups were genotyped, to identify specific SNPs: IL-8 ⫺251TrA, CXCR-1 +2607GrC, and CXCR-2 +785TrC (table 2). The allele frequencies of these SNPs showed notable ethnic divergence, a finding consistent with previous reports [25, 26]. For example, the IL-8 ⫺251A allele presents in whites with an allele frequency of 0.37, compared with 0.75 in African Americans. Nevertheless, all genotypic distributions from the different study groups conformed to the Hardy-Weinberg equilibrium. When comparing allele frequencies of these SNPs between case and control groups, the IL-8 ⫺251A allele showed signif- icantly higher frequencies in case groups than in control groups (white, 0.52 vs. 0.37 [P ! .002]; African Americans, 0.79 vs. 0.71 [P ! .02]). No significant differences in allele frequencies of CXCR-1 +2607GrC and CXCR-2 +785TrC were observed between case patients and control subjects in either ethnicity. To identify whether the IL-8 ⫺251A allele was associated with adult clinical TB disease, we compared the distribution of IL8 ⫺251TrA genotypes between case patients and control subjects. In whites, homozygotes of the IL-8 ⫺251A allele presented at a higher frequency in the case group than in the control group (0.26 vs. 0.14; table 2) and showed an increased risk (odds ratio [OR], 3.41; 95% confidence interval [CI], 1.52–7.64; Pcorr ! .006), compared with homozygotes of the IL-8 ⫺251T allele. Heterozygotes of IL-8 ⫺251A and T alleles also showed a moderate risk (OR, 2.01; 95% CI, 1.06–3.80; Pcorr p .07), compared with homozygotes of the IL-8 ⫺251T allele. Similar risks for these genotypes were found among African Americans (OR, 3.46 for homozygotes and 3.39 for heterozygotes), even though frequencies of these genotypes were different between the 2 ethnicities (table 2). Linkage between the IL-8 locus and clinical TB disease in children. TDT is a powerful test for linkage between a genetic marker and a disease-susceptibility locus in the presence of an association. Hence, to confirm the involvement of IL-8 in human TB susceptibility, we conducted a TDT analysis with the 131 nuclear families, each including at least 1 child with TB. Of these families, 64 families with both parents available were informative for conventional TDT analysis by having at least Table 2. Associations between single-nucleotide polymorphisms (SNPs) in IL-8, CXCR-1, and CXCR-2 genes and clinical tuberculosis (TB) in adults. African American subjects White subjects SNP, genotype IL-8 ⫺251TrA TT TA Patients with TB (n p 106) Control subjects (n p 167 Patients with TB (n p 180) OR (95% CI) 42 (39.3) 50 (46.7) 23 (21.7) 55 (51.9) 1.0 2.01 (1.06–3.80)b 23 (13.8) 8 (4.4) 50 (29.9) 59 (32.8) 3.39 (1.40–8.25)c 15 (14.0) 28 (26.4) 3.41 (1.52–7.64) c 94 (56.3) 113 (62.8) 3.46 (1.48–8.08)c 89 (83.2) 17 (15.9) 91 (85.8) 13 (12.3) 1.0 0.75 (0.34–1.63) 107 (64.1) 53 (31.7) 112 (62.2) 61 (33.9) 1.0 1.10 (0.70–1.73) 1 (0.01) 1 (0.01) 0.98 (0.60–15.88) 7 (4.2) 7 (3.9) 0.96 (0.32–2.82) 21 (19.6) 54 (50.5) 32 (29.9) 24 (22.6) 45 (42.5) 37 (34.9) 1.0 0.72 (0.36–1.48) 1.01 (0.48–2.15) 77 (46.1) 82 (49.1) 8 (4.8) 80 (44.4) 86 (47.8) 14 (7.8) 1.0 1.00 (0.65–1.56) 1.68 (0.67–4.24) OR (95% CI) a AA CXCR-1 +2607GrC GG GC CC CXCR-2 +785TrCa TT TC CC Control subjects (n p 107) 1.0 a NOTE. Data are no. (%) of subjects. P values were corrected for multiple comparisons by the formula (Pcorr p 1 ⫺ (1 ⫺ P )n , where P is the uncorrected P value and n is the number of comparisons). Pcorr ! .05 was considered to be statistically significant. a ⫺251TrA, corresponding to the position 251 nt upstream of transcription start point of IL-8; +2607GrC, position 6334 of GenBank sequence L19592; +785TrC, position 10657 of GenBank sequence M99412. b Pcorr p .07. c Pcorr ! .01. IL-8 and Human Tuberculosis • JID 2003:188 (1 August) • 351 Table 3. Transmission of the IL-8 ⫺251A allele within 64 informative families for conventional transmission-disequilibrium test. Transmission of IL-8 ⫺251A allele Transmitted Nontransmitted Percentage transmitted Children with TB (np 72) 50 32 61 Siblings without TB (n p 74) 38 46 45 Affected status NOTE. a b TB, tuberculosis. a 95% confidence interval, 51–71 (x2 p 3.95 ; P ! .05 ). These results were calculated by conventional transmission-disequilibrium test analysis described elsewhere [29, 30]. b The transmission of the IL-8 ⫺251A allele to siblings without TB was significantly less frequent than to the siblings with TB (P p .04). 1 parent who was heterozygous for the IL-8 ⫺251TrA polymorphism. Specifically, in 53 families, 1 parent was heterozygous, and in 11 families, both parents were heterozygous. Seven families had 11 affected child (multiplex family). A total of 82 transmissions of IL-8 ⫺251A or T alleles occurred from heterozygous parents to 72 children with TB, in which the IL-8 ⫺251A allele was transmitted significantly more often than expected (transmission percentage, 61%; 95% CI, 51%–71%; P ! .05; table 3), whereas the proportion of the IL-8 ⫺251A allele transmitted from heterozygous parents to unaffected children was 45%. The difference was statistically significant (P p .04). Consequently, this result provided evidence for a linkage between the marker IL-8 ⫺251TrA and TB susceptibility without evidence for segregation distortion. In addition, 12 informative families with only 1 parent but at least 1 unaffected sibling having a different genotype were eligible for S-TDT analysis. The IL-8 ⫺251A allele was observed more frequently among children with TB than among those without TB (0.69 vs. 0.55) (table 4). Because of the small sample size of only 12 sibships, we combined conventional TDT and S-TDT as an overall test, as described by Spielman et al. [29]. The Z statistic was 2.04, inferring a P value of .02 by use of the normal distribution approximation [29]. Therefore, this result supports our finding in the adult case-control study and implies that the IL-8 locus harbors a TB-susceptibility gene or genes, most likely IL-8 itself. DISCUSSION Accumulated evidence indicates that IL-8 is an important mediator of host response to and pathogenesis of a variety of microbes causing common human diseases, including TB. However, a recent genomewide linkage study indicated no evidence for linkage between human TB susceptibility and loci of IL-8 or its receptor genes CXCR-1 and CXCR-2 in African blacks [31]. Nonetheless, the candidate gene–based association study has been considered more powerful than the linkage study in determination of genetic susceptibility to human complex diseases such as TB disease [32]. In the present study, we used 352 • JID 2003:188 (1 August) • Ma et al. 2 strategies, a population-based association study (i.e., the casecontrol study) and a family-based association study (i.e., the TDT) to explore contribution of IL-8, CXCR-1, and CXCR-2 genes in human TB susceptibility. The case-control study is capable of detecting subtle genetic risks in complex diseases by providing an estimate of relative risk (i.e., OR), but bias may exist as a result of population admixture or stratification, existing in ethnically and racially mixed American populations. In contrast, TDT that used within-family control subjects minimizes or eliminates this population structure bias but has the limitation of being unable to measure relative risk directly. In practice, as a test of linkage, TDT has shown robust power for identification of markers closely linked to disease-susceptible genes [28]. Therefore, the combination of these 2 complementary approaches has satisfied some criteria for reliable results in genetic association studies in common diseases [33]. Our results from the adult case-control study initially suggested that the IL-8 ⫺251A allele was associated with an increased TB disease risk for its carrier with a dominant mode. Moreover, an OR 13.0 for homozygotes of the IL-8 ⫺251A allele, compared with homozygotes of the IL-8 ⫺251T allele, was consistently observed in the 2 ethnicities. This finding suggests that IL-8 may play a more prominent role in TB susceptibility, compared with other TB-associated genes, such as NRAMP1, which have polymorphisms with ORs !3.0 in our studied population [34] and other populations [35, 36]. Second, the TDT result from 76 informative families suggests that a linkage exists between the IL-8 locus and human susceptibility to TB disease by showing preferential transmission of the IL-8 ⫺251A allele to the affected children. Taken together, Table 4. Allele frequencies of IL-8 ⫺251A in 12 informative families for sibling transmission-disequilibrium test. IL-8 ⫺251TrA Affected status ⫺251A allele ⫺251T allele Children with TB (n p 13) 18 (0.69) 8 (0.31) Siblings without TB (n p 26) 31 (0.55) 21 (0.45) NOTE. Data are no. (% frequency) of alleles. TB, tuberculosis. our data indicate linkage and association between IL-8 and susceptibility to TB disease in adults and children. Thus, we propose that IL-8 is one of the important genes governing human genetic susceptibility to TB disease. In addition, higher IL-8 ⫺251A allele frequency in African American than in white subjects may contribute to a reported enhanced susceptibility of African Americans to TB disease than whites when exposed to similar environments [37]. It is notable that the IL-8 ⫺251A allele presents different allele frequencies in our studied populations from the previous reports in the subpopulations of Europe and Africa [26, 27]. These variations are likely the result of the heterogeneity of gene pool of ethnically and racially mixed American populations. Of interest, our family-based TDT analysis systematically rule out the possibility of biased associations in the population-based case-control study. To help minimize possible self-selection bias in recruiting control subjects from hospitals and clinics, we used the control recruitment criteria of no history of TB disease, autoimmune diseases, or other infectious diseases. In addition, the similar relative risks of IL-8 ⫺251A genotypes between white and African American subjects also decreased the likelihood of an artificial association between IL-8 gene and human genetic susceptibility to TB disease. Functional studies on the 5 flanking region of the IL-8 gene reveal several binding sites for transcriptional factors activator protein–1, NF–IL-6, and NF-kB, which are sufficient for maximal transcriptional responses to most proinflammatory mediators [38]. Of interest, all these binding sites are located within a narrow range of 100 nt and are close to the transcription start point (⫺130 nt) of IL-8. Only 2 rare SNPs in this region of IL-8 are registered in the GenBank database, dbSNP, indicating conservation and functional importance of the promoter. However, IL-8 ⫺251TrA (⫺251 nt upstream of the transcription start point) is located outside of this region, and it is in an area not characterized as a transcription factor binding site. Recently, a TDT study suggested that an unusual haplotype of IL-8 ⫺251A/781T (781T/C, another SNP in intron 1 of IL8), rather than IL-8 ⫺251A itself, was linked with genetic predisposition to respiratory syncytial virus infection [27]. However, our data from patients with TB showed that this haplotype was not preferentially transmitted to the affected children (52% transmitted; 95% CI, 46%–58%; P p .60). A further study with a larger sample size is necessary to clarify the association between this particular haplotype and human TB susceptibility. To date, only one in vitro study suggests that IL-8 ⫺251TrA alters IL-8 expression (i.e., expression was increased) [26]. Why might a higher expression of IL-8 cause a risk to clinical TB? One explanation may be that increased expression of IL8 attracts an excess of leukocytes to the disease site, resulting in extensive tissue damage, often seen in pulmonary TB by generation of damaging free radicals, proteases, and elastases. Recent observations confirmed that the high IL-8 secretion could also enhance the inflammation by delaying the apoptosis of PMNLs [39, 40]. At this point, the outcome of M. tuberculosis infection may not only depend on the virulence of M. tuberculosis, but also the host inflammatory response. Therefore, the IL-8 ⫺251A allele or other functional polymorphisms in strong linkage disequilibrium with the IL-8 ⫺251A allele are in need of further investigation—in particular, because 10 of the human CXC chemokine genes are also physically mapped on the same chromosome region 4q in addition to IL-8 [41]. Neither genotypes nor allele frequencies of CXCR-1 +2607GrC and CXCR-2 +785TrC showed significant difference between case patients with TB and control subjects without TB. CXCR-1 +2607GrC results in a conservative amino acid substitution from serine to threonine at the 276 amino acid residue of CXCR-1, which is located between the sixth and seventh putative transmembrane domains [42]. It is unlikely that this substitution makes a significant change in the structure and function of the CXCR-1 protein. CXCR-2 +785TrC is a silent substitution in exon 11 of the CXCR-2 gene. An association between systemic sclerosis and CXCR-2 +785TrC was detected in a case-control study, indicating it might be in strong linkage disequilibrium with other functional polymorphisms [25]. In addition to IL-8, CXCR-2 can bind other chemokines with high affinity, such as the growth-related oncogene proteins [43] and neutrophil-activating peptide 2 [44]; CXCR-1 does not. Moreover, CXCR-2 is predominantly expressed on monocytes and IL-8 receptor-positive lymphocytes [21]. These observations imply that CXCR-2 mediates functions of IL-8 different from CXCR-1 and may be involved in the pathogenesis of certain diseases such as systemic sclerosis, rather than other diseases such as TB. The lack of association with the CXCR receptor SNPs could also be the result of the small sample size; thus, additional studies with larger population pools are needed to confirm these findings. In summary, our results indicate an association between IL-8 and human genetic susceptibility to TB. The design of our study satisfied the criteria of a reliable genetic association study. For instance, results in the case-control study were independently obtained and confirmed from 2 ethnicities. Subsequently, the finding from the population-based study was supported by results from the family-based association study. Hence, the potential biases from either of both methods have been minimized. Acknowledgments We thank Kimmo Virtaneva and Frank DeLeo for their critical review of a draft of the manuscript. IL-8 and Human Tuberculosis • JID 2003:188 (1 August) • 353 References 1. Broaddus VC, Hebert CA, Vitangcol RV, Hoeffel JM, Bernstein MS, Boylan AM. Interleukin-8 is a major neutrophil chemotactic factor in pleural liquid of patients with empyema. Am Rev Respir Dis 1992; 146:825–30. 2. Pace E, Gjomarkaj M, Melis M, et al. Interleukin-8 induces lymphocyte chemotaxis into the pleural space: role of pleural macrophages. Am J Respir Crit Care Med 1999; 159:1592–9. 3. Gerszten RE, Garcia-Zepeda EA, Lim YC, et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 1999; 398:718–23. 4. Dlugovitzky D, Rateni L, Torres-Morales A, et al. Levels of interleukin8 in tuberculous pleurisy and the profile of immunocompetent cells in pleural and peripheral compartments. Immunol Lett 1997; 55:35–9. 5. Sadek MI, Sada E, Toossi Z, Schwander SK, Rich EA. Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis. Am J Respir Cell Mol Biol 1998; 19:513–21. 6. Mastroianni CM, Paoletti F, Rivosecchi RM, et al. Cerebrospinal fluid interleukin 8 in children with purulent bacterial and tuberculous meningitis. Pediatr Infect Dis J 1994; 13:1008–10. 7. Bergeron A, Bonay M, Kambouchner M, et al. Cytokine patterns in tuberculous and sarcoid granulomas: correlations with histopathologic features of the granulomatous response. J Immunol 1997; 159:3034–43. 8. Friedland JS, Hartley JC, Hartley CG, Shattock RJ, Griffin GE. Inhibition of ex vivo proinflammatory cytokine secretion in fatal Mycobacterium tuberculosis infection. Clin Exp Immunol 1995; 100:233–8. 9. Ribeiro-Rodrigues R, Resende Co T, Johnson JL, et al. Sputum cytokine levels in patients with pulmonary tuberculosis as early markers of mycobacterial clearance. Clin Diagn Lab Immunol 2002; 9:818–23. 10. Riedel DD, Kaufmann SH. Chemokine secretion by human polymorphonuclear granulocytes after stimulation with Mycobacterium tuberculosis and lipoarabinomannan. Infect Immun 1997; 65:4620–3. 11. Friedland JS, Remick DG, Shattock R, Griffin GE. Secretion of interleukin-8 following phagocytosis of Mycobacterium tuberculosis by human monocyte cell lines. Eur J Immunol 1992; 22:1373–8. 12. Zhang Y, Broser M, Cohen H, et al. Enhanced interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its components. J Clin Invest 1995; 95:586–92. 13. Smyth MJ, Zachariae CO, Norihisa Y, Ortaldo JR, Hishinuma A, Matsushima K. IL-8 gene expression and production in human peripheral blood lymphocyte subsets. J Immunol 1991; 146:3815–23. 14. Lin Y, Zhang M, Barnes PF. Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis. Infect Immun 1998; 66:1121–6. 15. Strieter RM, Kunkel SL, Showell HJ, et al. Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta. Science 1989; 243:1467–9. 16. Duque N, Gomez-Guerrero C, Egido J. Interaction of IgA with Fc alpha receptors of human mesangial cells activates transcription factor nuclear factor–kappa B and induces expression and synthesis of monocyte chemoattractant protein-1, IL-8, and IFN-inducible protein 10. J Immunol 1997; 159:3474–82. 17. Wickremasinghe MI, Thomas LH, Friedland JS. Pulmonary epithelial cells are a source of IL-8 in the response to Mycobacterium tuberculosis: essential role of IL-1 from infected monocytes in a NF-kappaB– dependent network. J Immunol 1999; 163:3936–47. 18. Ameixa C, Friedland JS. Interleukin-8 secretion from Mycobacterium tuberculosis–infected monocytes is regulated by protein tyrosine kinases but not by ERK1/2 or p38 mitogen-activated protein kinases. Infect Immun 2002; 70:4743–6. 19. Nau GJ, Richmond JF, Schlesinger A, Jennings EG, Lander ES, Young RA. Human macrophage activation programs induced by bacterial pathogens. Proc Natl Acad Sci USA 2002; 99:1503–8. 20. Larsen CG, Thomsen MK, Gesser B, et al. The delayed-type hypersensitivity reaction is dependent on IL-8: inhibition of a tuberculin 354 • JID 2003:188 (1 August) • Ma et al. 21. 22. 23. 24. 25. 26. 27. 28. 29. 30. 31. 32. 33. 34. 35. 36. 37. 38. 39. 40. 41. skin reaction by an anti–IL-8 monoclonal antibody. J Immunol 1995; 155:2151–7. Chuntharapai A, Lee J, Hebert CA, Kim KJ. Monoclonal antibodies detect different distribution patterns of IL-8 receptor A and IL-8 receptor B on human peripheral blood leukocytes. J Immunol 1994; 153: 5682–8. Jones SA, Wolf M, Qin S, Mackay CR, Baggiolini M. Different functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2. Proc Natl Acad Sci USA 1996; 93:6682–6. Meddows-Taylor S, Martin DJ, Tiemessen CT. Reduced expression of interleukin-8 receptors A and B on polymorphonuclear neutrophils from persons with human immunodeficiency virus type 1 disease and pulmonary tuberculosis. J Infect Dis 1998; 177:921–30. Meddows-Taylor S, Martin DJ, Tiemessen CT. Impaired interleukin8–induced degranulation of polymorphonuclear neutrophils from human immunodeficiency virus type 1–infected individuals. Clin Diagn Lab Immunol 1999; 6:345–51. Renzoni E, Lympany P, Sestini P, et al. Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis. Arthritis Rheum 2000; 43:1633–40. Hull J, Thomson A, Kwiatkowski D. Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax 2000; 55:1023–7. Hull J, Ackerman H, Isles K, Usen S, Pinder M, Thomson A, Kwiatkowski D. Unusual haplotypic structure of IL8, a susceptibility locus for a common respiratory virus. Am J Hum Genet 2001; 69:413–9. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52:506–16. Spielman RS, Ewens WJ. A sibship test for linkage in the presence of association: the sib transmission/disequilibrium test. Am J Hum Genet 1998; 62:450–8. Lie BA, Todd JA, Pociot F, et al. The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non–class II gene. Am J Hum Genet 1999; 64:793–800. Bellamy R, Beyers N, McAdam KP, et al. Genetic susceptibility to tuberculosis in Africans: a genome-wide scan. Proc Natl Acad Sci USA 2000; 97:8005–9. Spielman RS, Ewens WJ. The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Genet 1996; 59:983–9. Dahlman I, Eaves IA, Kosoy R, et al. Parameters for reliable results in genetic association studies in common disease. Nat Genet 2002; 30: 149–50. Ma X, Dou S, Wright JA, et al. 5 Dinucleotide repeat polymorphism of NRAMP1 and susceptibility to tuberculosis among Caucasian patients in Houston, Texas. Int J Tuberc Lung Dis 2002; 6:818–23. Bellamy R, Ruwende C, Corrah T, McAdam KP, Whittle HC, Hill AV. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med 1998; 338:640–4. Gao PS, Fujishima S, Mao XQ, et al. Genetic variants of NRAMP1 and active tuberculosis in Japanese populations. International Tuberculosis Genetics Team. Clin Genet 2000; 58:74–6. Stead WW, Senner JW, Reddick WT, Lofgren JP. Racial differences in susceptibility to infection by Mycobacterium tuberculosis. N Engl J Med 1990; 322:422–7. Roebuck KA. Regulation of interleukin-8 gene expression. J Interferon Cytokine Res 1999; 19:429–38. Kettritz R, Gaido ML, Haller H, Luft FC, Jennette CJ, Falk RJ. Interleukin-8 delays spontaneous and tumor necrosis factor–alpha– mediated apoptosis of human neutrophils. Kidney Int 1998; 53:84–91. Aleman M, Garcia A, Saab MA, et al. Mycobacterium tuberculosis– induced activation accelerates apoptosis in peripheral blood neutrophils from patients with active tuberculosis. Am J Respir Cell Mol Biol 2002; 27:583–92. Modi WS, Chen ZQ. Localization of the human CXC chemokine sub- family on the long arm of chromosome 4 using radiation hybrids. Genomics 1998; 47:136–9. 42. Holmes WE, Lee J, Kuang WJ, Rice GC, Wood WI. Structure and functional expression of a human interleukin-8 receptor. Science 1991; 253:1278–80. 43. Lee J, Horuk R, Rice GC, Bennett GL, Camerato T, Wood WI. Char- acterization of two high affinity human interleukin-8 receptors. J Biol Chem 1992; 267:16283–7. 44. Katancik JA, Sharma A, de Nardin E. Interleukin 8, neutrophil-activating peptide-2 and GRO-alpha bind to and elicit cell activation via specific and different amino acid residues of CXCR2. Cytokine 2000;12: 1480–8. IL-8 and Human Tuberculosis • JID 2003:188 (1 August) • 355